Latest Asx News

Orbminco Limited has announced the upcoming resignation of Managing Director Ralf Kriege, effective November 7, 2025, marking a significant leadership change for the copper and gold explorer.

Livium Ltd and Mineral Resources Ltd have formalised a 50 – 50 joint venture to commercialise the innovative LieNA® lithium processing technology, aiming to license it globally despite current market headwinds.

Envirosuite Limited’s acquisition by Ideagen Limited has received Federal Court approval, making the scheme legally effective and triggering imminent suspension of Envirosuite shares on the ASX.

Litchfield Minerals Limited has launched a $1.5 million capital raising to fast-track exploration at its Northern Territory copper-zinc projects, including the advanced Oonagalabi asset. Recent drilling and geophysical surveys highlight promising mineralisation and near-term growth potential.

Litchfield Minerals has successfully raised $500,000 through a targeted placement and is launching a $1 million Security Purchase Plan to fund upcoming drilling campaigns and working capital needs.

Dicker Data Limited has announced a fully franked quarterly dividend of AUD 0.11 per share, payable on 1 September 2025, alongside a Dividend Reinvestment Plan offering new shares at market-based pricing.

Scentre Group has announced an ordinary dividend of AUD 0.08815 per security for the half-year ended 30 June 2025, payable on 29 August. The dividend is fully unfranked and includes a Dividend Reinvestment Plan with no discount.

Credit Intelligence Limited has issued a profit warning revealing a reduced loss of approximately A$4.5 million for FY25, down from A$12.5 million the previous year, driven by strategic divestments and a revenue decline.

Vertex Minerals has initiated underground mining at its Reward Gold Mine, marking a significant shift to high-grade gold extraction. The company is progressing steadily with infrastructure and mining fronts to sustain continuous production.

Island Pharmaceuticals has raised $350,000 through an options exercise by substantial shareholder MWP Partners, reinforcing confidence in its antiviral drug development pipeline.

AXP Energy has raised A$2.7 million through a two-tranche placement to expand its innovative gas-to-power-bitcoin mining operations and accelerate oil and gas drilling activities in Oklahoma.

Syntara Limited is set to update investors on the clinical progress of its lead drug candidate amsulostat, targeting myelofibrosis, in a webinar scheduled for 11 August 2025. The company highlights recent regulatory milestones and advancing trials.